期刊文献+

滋阴平肝化瘀汤治疗肾性高血压临床研究 被引量:20

Clinical Study on Nourishing Yin Liver to Remove Stasis Soup Treatment of Kidney High Blood Pressure
下载PDF
导出
摘要 目的:观察中西医结合方法治疗肾性高血压的临床疗效。方法:将129例住院患者采用随机数字表法分为两组,对照组43例采用单纯西药疗法治疗,治疗组86例在对照组的基础上加用中药滋阴平肝化瘀汤治疗。结果:治疗组在改善临床症状,血压及实验室指标等方面,均优于对照组(P<0.05或0.01)。中西医结合治疗肾性高血压疗效明显优于单纯西药治疗。结论:中西医结合方法治疗肾性高血压疗效显著。 Objective:To observe the clinical curative effect of method of combining traditional Chinese and western medicine treatment of renal hypertension.Methods:129 patients hospitalized patients were randomly divided into two groups:control group(43 cases by the pure western medicine therapy,the treatment group 86 examples nourishing yin liver to remove stasis with Chinese traditional medicine treatments in the control group basis.Results:Treatment group in improved clinical symptoms,blood pressure and laboratory parameters are better than control group,P0.05 or 0.01.Combining traditional Chinese and western medicine treatment of renal hypertension curative effect is better than pure western medicine.Conclusion:The method of combining traditional Chinese and western medicine treatment of renal hypertension curative effect is distinct.
出处 《中医学报》 CAS 2011年第11期1347-1349,共3页 Acta Chinese Medicine
关键词 肾性高血压 滋阴平肝化瘀汤 降压药 钙拮抗剂 临床观察 Kidney of hypertension Nourishing yin liver to remove stasis soup deincrease pressure drugs Calcium channel blockers Clinical observation
  • 相关文献

参考文献10

二级参考文献21

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2[1]Ruilope LM,Salvetti A,Jamerson K,et aL Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study[J].J Am Soc Nephrol,2001,12(2):218-225.
  • 3[2]Maschio G,Alberti D,LocateUi F,et aL Angiotensin-converting enzyme inhibitors and kidney protection:the AIPRI triaL The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group[J].J Cardiovasc Pharmacol,1999,33(suppl 1):S16-20.
  • 4[3]Hou FF,Zhang X,Zhang GH,et al.Efficacy and safety of benazepril for advanced chronic renal insufficiency[J].N Engl J Med,2006,354 (2):131-140.
  • 5[4]Ruggenenti P,Pema A,Gherardi G,et aL Renal function and require-ment for dialysis in chronic nephropathy patients on long-term ramipril:REIN follow-up trial.Gruppo Italiano di Studi Epidemiologici in Nefrolo-gia (GISEN)[J].Lancet,1998,352(9136):1252-1256.
  • 6[5]Parring HH,Lehnert H,Brochner MJ,et aL The effect of irbesartan on the development of diabetic ncphropathy in patients with type 2 diabetes[J].N Engl J Med,2001,345(12):870-878.
  • 7[6]Giancarlo V,Nigel MW.Microalbuminuria reduction with valsartan in patients with type-2 diabetes mellitus:a blood pressure-independent effect[J].Circulation,2002,106(3):672-678.
  • 8[7]Lewis EJ,Nunsicker LG,Clarke WR,et aL Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephrcpathy due to type 2 diabetes[J].N Engl J Med,2001,345(12):851-860.
  • 9[8]Brenner BM,Cooper ME,Zecuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2diabetes and nephrop-athy[J].New Engl J Meal,2001,345(12):861-869.
  • 10[9]Julius S,Kjeldsen SE,Weber M,et aL Outcomes in hypertensive pa-tients at high cardiovascular risk treated with regimens based on valsrtan or andodipine:the VALUE randomized trial[J].Lancet,2004,363(9426):2022-2031.

共引文献80

同被引文献205

引证文献20

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部